← All Nexien Biopharma, INC filings

Nexien Biopharma, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

OTC.Pink
NXEN
Nexien Biopharma, INC
Form 4: Nexien BioPharma CEO Acquires 1,000,000 Shares in Compensation Deal
Richard S. Greenberg, CEO of Nexien BioPharma, acquired 1,000,000 shares of common stock on May 23, 2024, as compensation for services.
OTC.Pink
NXEN
Nexien Biopharma, INC
Form 4: Nexien BioPharma CFO Evan L. Wasoff Reports Acquisition of 2,000,000 Shares
Nexien BioPharma's CFO, Evan L. Wasoff, reports acquiring 2,000,000 shares of common stock and discloses holdings of derivative securities.